19-17973952-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001386974.1(KCNN1):​c.64G>A​(p.Gly22Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000994 in 1,408,332 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000099 ( 0 hom. )

Consequence

KCNN1
NM_001386974.1 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.638

Publications

0 publications found
Variant links:
Genes affected
KCNN1 (HGNC:6290): (potassium calcium-activated channel subfamily N member 1) Action potentials in vertebrate neurons are followed by an afterhyperpolarization (AHP) that may persist for several seconds and may have profound consequences for the firing pattern of the neuron. Each component of the AHP is kinetically distinct and is mediated by different calcium-activated potassium channels. The protein encoded by this gene is activated before membrane hyperpolarization and is thought to regulate neuronal excitability by contributing to the slow component of synaptic AHP. The encoded protein is an integral membrane protein that forms a voltage-independent calcium-activated channel with three other calmodulin-binding subunits. This gene is a member of the KCNN family of potassium channel genes. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0971286).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNN1NM_001386974.1 linkc.64G>A p.Gly22Arg missense_variant Exon 2 of 10 ENST00000684775.1 NP_001373903.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNN1ENST00000684775.1 linkc.64G>A p.Gly22Arg missense_variant Exon 2 of 10 NM_001386974.1 ENSP00000507021.1 Q92952-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000127
AC:
2
AN:
157468
AF XY:
0.0000232
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000322
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000994
AC:
14
AN:
1408332
Hom.:
0
Cov.:
31
AF XY:
0.0000101
AC XY:
7
AN XY:
696342
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32146
American (AMR)
AF:
0.00
AC:
0
AN:
36438
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25180
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36638
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80884
European-Finnish (FIN)
AF:
0.0000433
AC:
2
AN:
46194
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5700
European-Non Finnish (NFE)
AF:
0.0000110
AC:
12
AN:
1086680
Other (OTH)
AF:
0.00
AC:
0
AN:
58472
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.00000883
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 11, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.64G>A (p.G22R) alteration is located in exon 3 (coding exon 1) of the KCNN1 gene. This alteration results from a G to A substitution at nucleotide position 64, causing the glycine (G) at amino acid position 22 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.092
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
6.1
DANN
Benign
0.83
DEOGEN2
Benign
0.17
T;.;.
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.035
N
LIST_S2
Benign
0.75
T;T;T
M_CAP
Benign
0.0066
T
MetaRNN
Benign
0.097
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L;.;.
PhyloP100
0.64
PrimateAI
Uncertain
0.56
T
REVEL
Benign
0.050
Sift4G
Benign
1.0
T;T;T
Polyphen
0.62
P;.;.
Vest4
0.14
MutPred
0.28
Gain of methylation at G22 (P = 0.0383);.;Gain of methylation at G22 (P = 0.0383);
MVP
0.22
MPC
0.61
ClinPred
0.12
T
GERP RS
2.2
Varity_R
0.035
gMVP
0.27
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs773354965; hg19: chr19-18084761; API